US 11028068
Somatostatin modulators and uses thereof
granted A61KA61K9/0053
Quick answer
US patent 11028068 (Somatostatin modulators and uses thereof) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRINETICS PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K9/0053